Evaluación funcional cardiovascular en hipertensos tratados con enalapril durante 6 meses

Introduction and objectives: Hypertension affects approximately 30% of adults worldwide, and is a cardiovascular and cerebrovascular risk factor. Ergometry and echocardiography are not routine tests, but allow obtaining guiding parameters of cardiovascular functional capacity. The objective was to compare these parameters in hypertensive patients after treatment with enalapril. Method: A quasi-experimental, prospec-tive study was performed in 38 patients, who underwent ergometry and echocardiography before and after enalapril monotherapy (10-20 mg/day) for 6 months. Ergometric and echocardiographic variables were assessed. Results: Males were predominant (63%), the average age was 39 years, 89.5% were stage I hypertensive subjects, there were no stage III hypertensive subjects, and secondary hypertension was excluded. At both times of study obese subjects were predominant. At 6 months there was a reduction of systolic and diastolic blood pressures both at rest and during physical exertion, which was significant for the systolic (p